Birchview Capital’s Acceleron Pharma Inc. XLRN Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2021
Q4 | – | Sell |
-10,672
| Closed | -$1.84M | – | 70 |
|
|
2021
Q3 | $1.84M | Sell |
10,672
-8,000
| -43% | -$1.38M | 1.25% | 13 |
|
|
2021
Q2 | $2.34M | Hold |
18,672
| – | – | 1.4% | 13 |
|
|
2021
Q1 | $2.53M | Hold |
18,672
| – | – | 1.5% | 11 |
|
|
2020
Q4 | $2.39M | Hold |
18,672
| – | – | 1.38% | 15 |
|
|
2020
Q3 | $2.1M | Hold |
18,672
| – | – | 1.4% | 11 |
|
|
2020
Q2 | $1.78M | Hold |
18,672
| – | – | 1.08% | 16 |
|
|
2020
Q1 | $1.68M | Hold |
18,672
| – | – | 1.49% | 11 |
|
|
2019
Q4 | $990K | Hold |
18,672
| – | – | 0.72% | 23 |
|
|
2019
Q3 | $738K | Hold |
18,672
| – | – | 0.49% | 20 |
|
|
2019
Q2 | $767K | Hold |
18,672
| – | – | 0.47% | 22 |
|
|
2019
Q1 | $870K | Hold |
18,672
| – | – | 0.55% | 21 |
|
|
2018
Q4 | $813K | Buy |
18,672
+6,672
| +56% | +$291K | 0.77% | 17 |
|
|
2018
Q3 | $687K | Hold |
12,000
| – | – | 0.44% | 25 |
|
|
2018
Q2 | $582K | Sell |
12,000
-13,000
| -52% | -$631K | 0.4% | 26 |
|
|
2018
Q1 | $978K | Hold |
25,000
| – | – | 0.64% | 14 |
|
|
2017
Q4 | $1.06M | Hold |
25,000
| – | – | 0.62% | 13 |
|
|
2017
Q3 | $933K | Buy |
25,000
+10,000
| +67% | +$373K | 0.48% | 15 |
|
|
2017
Q2 | $456K | Buy |
+15,000
| New | +$456K | 0.24% | 27 |
|